Adolfo, Roshaine .
HRN: 20-55-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2022
AMPICILLIN 250MG (VIAL)
08/13/2022
08/20/2022
IVT
170mg
Q6
T/C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes